Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Ascending colon

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    25 result(s) found for: Ascending colon. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2007-004994-25 Sponsor Protocol Number: CSMS995A2101 Start Date*: 2008-02-04
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A multi-center, randomized, double-blind, placebo-controlled, crossover study in women with irritable bowel syndrome to evaluate feasibility and reproducibility of barostat assessments of colorecta...
    Medical condition: Irritable Bowel Syndrom
    Disease: Version SOC Term Classification Code Term Level
    9.1 10023003 Irritable bowel syndrome PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2007-003735-23 Sponsor Protocol Number: FE999169 Start Date*: 2008-11-24
    Sponsor Name:Ferring Pharmaceuticals Ltd.
    Full Title: A prospective, randomised study comparing a 3-sachet Picolax® treatment with the standard 2-sachet Picolax® for bowel cleansing prior to colonoscopy.
    Medical condition: Bowel preparation prior to elective complete colonoscopy. As 'bowel preparation' is not a specific medical condition, there is no MedDRA term.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-001062-10 Sponsor Protocol Number: 000121 Start Date*: 2014-11-03
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, assessor-blinded, multi-centre trial comparing the efficacy, safety and tolerability of the PICOPREP tailored dosing schedule to the PICOPREP day-before dosing schedule for colon clea...
    Medical condition: Bowel cleansing
    Disease: Version SOC Term Classification Code Term Level
    17.1 10042613 - Surgical and medical procedures 10066943 Bowel preparation PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-000259-33 Sponsor Protocol Number: 06-AnIt-06 Start Date*: 2007-08-16
    Sponsor Name:Department of Anesthesiology and Intensive Care, University Hospital Münster
    Full Title: Perioperative protective effects of lidocaine - clinical study on the route and timing of administration
    Medical condition: patients, scheduled for major elective colorectal surgery
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10040668 Sigmoid hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10009879 Colectomy total PT
    14.0 10042613 - Surgical and medical procedures 10059848 Proctocolectomy PT
    14.0 10042613 - Surgical and medical procedures 10019460 Hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10039153 Right hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10024107 Left hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10063950 Ileocolectomy PT
    14.0 10042613 - Surgical and medical procedures 10042609 Surgery PT
    14.0 10042613 - Surgical and medical procedures 10061778 Colectomy PT
    14.0 10042613 - Surgical and medical procedures 10044083 Total colectomy LLT
    14.0 10042613 - Surgical and medical procedures 10009878 Colectomy partial LLT
    14.0 10042613 - Surgical and medical procedures 10009880 Colectomy transverse LLT
    14.0 10042613 - Surgical and medical procedures 10033684 Panproctocolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10044447 Transverse colectomy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-017595-25 Sponsor Protocol Number: 04-AnIt-09/UKM09_0031 Start Date*: 2011-02-22
    Sponsor Name:University Hospital Muenster
    Full Title: Balanced 6 % HES 130/0.4 vs. balanced crystalloid-based infusion in patients undergoing colorectal surgery
    Medical condition: Patients undergoing colorectal surgery
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10040668 Sigmoid hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10009879 Colectomy total PT
    14.1 10042613 - Surgical and medical procedures 10059848 Proctocolectomy PT
    14.1 10042613 - Surgical and medical procedures 10009877 Colectomy NOS LLT
    14.1 10042613 - Surgical and medical procedures 10019460 Hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10039153 Right hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10024107 Left hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10063950 Ileocolectomy PT
    14.1 10042613 - Surgical and medical procedures 10061778 Colectomy PT
    14.1 10042613 - Surgical and medical procedures 10044083 Total colectomy LLT
    14.1 10042613 - Surgical and medical procedures 10009878 Colectomy partial LLT
    14.1 10042613 - Surgical and medical procedures 10063065 Anterior rectum resection LLT
    14.1 10042613 - Surgical and medical procedures 10009880 Colectomy transverse LLT
    14.1 10042613 - Surgical and medical procedures 10033684 Panproctocolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10044447 Transverse colectomy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-005694-23 Sponsor Protocol Number: CB-17-01/05 Start Date*: 2011-12-20
    Sponsor Name:COSMO TECHNOLOGIES LTD
    Full Title: Polyp detection rate after single oral dose of methylene blue MMX(R) modified release tablets administered to subjects undergoing outpatients colonoscopy
    Medical condition: patients scheduled for the screening or surveillance colonoscopy and meeting the joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the Ameri...
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022891 - Investigations 10014805 Endoscopy PT
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10048832 Colon adenoma PT
    14.1 10017947 - Gastrointestinal disorders 10048646 Polyp colorectal PT
    Population Age: Newborns, Infants and toddlers, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-000419-42 Sponsor Protocol Number: Nalogexol-2014 Start Date*: 2015-05-11
    Sponsor Name:Aalborg University Hospital
    Full Title: Naloxegol and assessments of opioid induced bowel dysfunction
    Medical condition: Healthy volunteers (Opioid-induced bowel dysfunction)
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004856 10071128 Opioid induced constipation LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2018-003304-39 Sponsor Protocol Number: 007 Start Date*: 2019-01-23
    Sponsor Name:Morten Rasmussen
    Full Title: Efficacy of a novel 1l PEG plus ascorbate (Plenvu) bowel preparation vs. 2l PEG plus ascorbate (Moviprep), a randomized controlled multicenter trial
    Medical condition: Bowel preparation before colonoscopy
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022891 - Investigations 10017971 Gastrointestinal investigations HLGT
    21.1 10042613 - Surgical and medical procedures 10066943 Bowel preparation PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2013-002506-31 Sponsor Protocol Number: REPREB1 Start Date*: 2013-12-16
    Sponsor Name:Dr Antonio Gimeno
    Full Title: Clinical trial phase IV, randomized, to evaluate the efficacy of Polyethylene glycol plus ascorbic acid vs Polyethylene glycol alone in patients with a history of poorly prepared colonoscopy .
    Medical condition: outpatients with past poor bowel preparation, defined as a score less than 5, according to the Boston scale
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-004132-20 Sponsor Protocol Number: D9423C00001 Start Date*: 2016-07-28
    Sponsor Name:AstraZeneca K.K.
    Full Title: A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn’s Disease in Japan
    Medical condition: Active Crohn’s Disease
    Disease: Version SOC Term Classification Code Term Level
    19.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2010-023494-19 Sponsor Protocol Number: KPT3-07/2010 Start Date*: 2011-02-10
    Sponsor Name:Dr. August Wolff GmbH & Co. KG Arzneimittel
    Full Title: A Phase IIa, Multi-Centre, Double-blind, Randomised, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of K(D)PT after Multiple Ascending Doses in Patients with Activ...
    Medical condition: Ulcerative colitis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2021-006617-11 Sponsor Protocol Number: 122021 Start Date*: 2022-06-07
    Sponsor Name:Region Nordjylland
    Full Title: A Randomised controlled trial to compare efficacy and tolerability of Plenvu® and Picoprep® as cleansing agents before colonoscopy
    Medical condition: The trial is about comparing the efficacy of Plenvu with Picoprep. Both are bowel cleansing agents prior to colonoscopy. The patients to be examined are all referred to exclude colorectal cancer di...
    Disease: Version SOC Term Classification Code Term Level
    27.0 10022891 - Investigations 10061839 Endoscopy large bowel LLT
    21.1 10042613 - Surgical and medical procedures 10066943 Bowel preparation PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2013-002116-27 Sponsor Protocol Number: HMPL-004-03 Start Date*: 2013-10-28
    Sponsor Name:Nutrition Science Partners Limited
    Full Title: A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients with Mild to Moderate Active Ulcerative Colitis (NATRUL-3)
    Medical condition: Ulcerative Colitis (UC)
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Prematurely Ended) HU (Prematurely Ended) LT (Prematurely Ended) CZ (Prematurely Ended) BG (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2015-000481-58 Sponsor Protocol Number: MLN0002SC-3031 Start Date*: 2016-01-22
    Sponsor Name:Takeda Development Centre Europe, Ltd.
    Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Cr...
    Medical condition: Crohn’s Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SK (Completed) CZ (Completed) NL (Completed) BG (Completed) GB (Completed) DE (Completed) BE (Completed) SE (Completed) DK (Completed) LT (Completed) HU (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-003364-36 Sponsor Protocol Number: GED-0301-UC-002 Start Date*: 2016-02-09
    Sponsor Name:Celgene Corporation
    Full Title: A Phase 2, Open-label, Multicenter Study to Explore the Efficacy and Safety of Mongersen (GED-0301) in Subjects with Active Ulcerative Colitis.
    Medical condition: Ulcerative Colitis.
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) SK (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2013-001540-60 Sponsor Protocol Number: MULTIPAIN6-2013 Start Date*: 2013-08-08
    Sponsor Name:Mech-Sense, Aalborg University Hospital
    Full Title: A novel approach to assess gastrointestinal adverse effects of opioids
    Medical condition: Opioid-induced bowel dysfunction.
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004856 10071128 Opioid induced constipation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2004-001109-81 Sponsor Protocol Number: MC/PR/1405/002/02 Start Date*: 2004-10-04
    Sponsor Name:Chiesi Farmaceutici SpA
    Full Title: A randomised, controlled with placebo, double blind, double dummy, parallel group study on the therapeutic efficacy and safety of Beclomethasone dipropionate (BDP) in the treatment of patients with...
    Medical condition: Active Crohn's ileitis
    Disease: Version SOC Term Classification Code Term Level
    6 10011401 high
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2011-003743-22 Sponsor Protocol Number: D9422C00001 Start Date*: Information not available in EudraCT
    Sponsor Name:AstraZeneca AB
    Full Title: A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
    Medical condition: Crohn's Disease
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-006957-42 Sponsor Protocol Number: BUG-2/CDA Start Date*: 2009-10-30
    Sponsor Name:Dr. Falk Pharma GmbH
    Full Title: Double-blind, double-dummy, randomised, comparative, multi-centre phase III study on the efficacy and tolerability of an 8-week oral treatment with 9 mg budesonide once daily vs. 3 mg budesonide th...
    Medical condition: Induction of remission in active Crohn´s disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 10017947 - Gastrointestinal disorders 10058815 Crohn's disease acute episode LLT
    14.1 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) HU (Completed) LT (Completed) BG (Completed) CZ (Completed) LV (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2015-001555-69 Sponsor Protocol Number: 4083-002 Start Date*: 2016-01-15
    Sponsor Name:Kyowa Kirin Pharmaceutical Development, Inc.
    Full Title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study (Induction Therapy) and Long-term Extension Therapy of an Anti-OX40 Monoclonal Antibody (KHK4083) ...
    Medical condition: Moderately Active Ulcerative Colitis, defined as: •Total Mayo Clinic score of 4 to 9 (range: 0 to 12, with higher scores indicating more disease activity); •Endoscopy subscore (mMES determined by ...
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10045365 Ulcerative colitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: HU (Completed) CZ (Completed) PL (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 15 16:52:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA